Stay up to date on the latest oncology and nursing conferences.
Choosing an Iron Chelation Therapy for a Patient with MDS
June 11th 2018Phyllis McKiernan, MSN, APN, OCN, Blood & Marrow Transplant Program, John Theurer Cancer Center explains factors that go into choosing an iron chelation therapy for a patient with myelodisplastic syndrome (MDS) experiencing transfusion-related iron overload.
Liso-Cel Shows Promise in High-Risk Diffuse Large B-Cell Lymphoma
June 7th 2018A promising CD19-directed chimeric antigen (CAR) T-cell therapy, Lisocabtagene maraleucel (JCAR017; liso-cel), may result in durable remissions among patients with high-risk diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma.
Mobile Monitoring Technology Helps to Reduce Symptom Severity in HNC
June 4th 2018Patients with head and neck cancer (HNC) who tracked their symptoms using the CYCORE (CYberinfrastructure for COmparative Effectiveness REsearch) system’s mobile and sensor technology experienced reduced symptom severity compared with those who received standard care, according to results of a large randomized trial.
Simple, Evidence-Based Decision Aid Can Help Previvors and Their Nurses Weigh Prevention Options
May 20th 2018When a woman learns she carries a BRCA gene mutation—and thus, in her lifetime, faces an 87% risk of developing breast cancer and a 63% risk of getting ovarian cancer—she has a difficult decision-making process ahead of her. One nurse created an easy-to-understand guide that explains all options and their pros and cons, for use by oncology nurses working with BRCA mutation carriers who do not have cancer—previvors.
Distance Caregivers Often Experience More Distress and Anxiety Than Patients
May 19th 2018“While there is substantial research documenting the psychosocial characteristics in cancer patients and local caregivers to date, none have focused solely on the comparison of patients with their distance caregivers,” the researchers stated in an abstract presented by AnnMarie Papik, B.S.
Changes in Olaparib Indications Demonstrate Need for Best Practices for Nurses
May 19th 2018As the Food and Drug Administration continues to approve additional indications for olaparib (Lynparza), health care providers and caregivers should be aware of the potential adverse effects (AEs) associated with treatment.
Nurses Should Explore the Value of Cardiac Monitoring Among Younger Breast Cancer Survivors
May 19th 2018Researchers recommended that survivors of younger-adult breast cancer learn and watch for the signs and symptoms of heart problems or failure, such as shortness of breath and fatigue, and always go to their follow-up appointments, where health care practitioners may keep tabs on their heart health.
Oncology Nurse Practitioners Can Streamline the Cancer Treatment Process
May 18th 2018How are patients with cancer triaged at key points throughout their journeys? Who helps them understand their diagnoses or treatments and prioritizes what to do next? Who pulls in the resources needed to make sure patients get what they need as expeditiously as possible?
Nurses Show Interest in Learning About LGBT Patients With Cancer
May 18th 2018A recent survey showed that nurses are willing to be trained in how to offer an affirmative healthcare experience to individuals who identify as lesbian, gay, bisexual, or transgender; however, only 4.7% were able to demonstrate knowledge of this patient community.
Managing Patients Treated with Venetoclax Plus Rituximab for Relapsed/Refractory CLL
May 18th 2018A multidisciplinary team approach may help in seeing optimal patient outcomes following the administration of a powerful drug combination for patients with relapsed/refractory chronic lymphocytic leukemia (CLL).